Find link

language:

Find link is a tool written by Edward Betts.

searching for H3 receptor antagonist 8 found (26 total)

Holger Stark (717 words) [view diff] exact match in snippet view article find links to article

co-inventor of the active ingredient Pitolisant, the only histamine H3 receptor antagonist approved to date. Stark pursued pharmacy studies at the Free University

List of investigational attention deficit hyperactivity disorder drugs (2,175 words) [view diff] exact match in snippet view article find links to article

agent [20] Bavisant (BEN-2001, JNJ-1074, JNJ-31001074) – histamine H3 receptor antagonist [21] BCWP-E003 – undefined mechanism [22] BLI-1008 – undefined mechanism

Chlorprothixene (1,276 words) [view diff] exact match in snippet view article find links to article

Ligneau X, Stark H (January 2009). "Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics". Bioorganic & Medicinal Chemistry

Chlorpromazine (5,375 words) [view diff] exact match in snippet view article find links to article

Ligneau X, Stark H (January 2009). "Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics". Bioorganic & Medicinal Chemistry

Maprotiline (5,053 words) [view diff] exact match in snippet view article find links to article

Ligneau X, Stark H (January 2009). "Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics". Bioorganic & Medicinal Chemistry

Idiopathic hypersomnia (5,215 words) [view diff] no match in snippet view article find links to article

obstructive sleep apnea. Pitolisant, a selective histamine 3 (H3) receptor antagonist/inverse agonist, was approved by FDA during August 2019. It works

Amitriptyline (8,668 words) [view diff] exact match in snippet view article find links to article

Ligneau X, Stark H (January 2009). "Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics". Bioorganic & Medicinal Chemistry

Pediatric narcolepsy (2,856 words) [view diff] no match in snippet view article find links to article

paralysis FDA approved for ages 7 and above Pitolisant histamine 3 (H3) receptor antagonist EDS/Cataplexy PDA approved for adults, in trials for use in a pediatric